home · filing · 0001824293-22-000007
8-K filed February 28, 2022, 6:59 PM ET
ticker GRI
CIK 0001824293
leadership
confidence high
sentiment positive
materiality 0.30
Vallon Pharmaceuticals adds Meenu Karson to board; Ofir Levi steps down from committees
GRI Bio, Inc.
Board expanded from 5 to 6 directors; Meenu Karson appointed as independent director.
Ofir Levi resigned from Audit and Nominating & Corporate Governance committees but remains Board Chair.
Karson appointed to Audit Committee and as Chair of Nominating & Corporate Governance Committee.
Karson is former President/CEO of Proteostasis Therapeutics, raised $300M+ and led IPO.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Meenu Karson
director
Effective 2022-02-23
Filed February 28, 2022, 6:59 PM ET
increased the size of the Board from five directors to six directors and appointed Meenu Karson to serve as a member of the Board
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Meenu Karson was appointed as director at GRI Bio, Inc..
Action appointed
Role director
Exact text from the filing
increased the size of the Board from five directors to six directors and appointed Meenu Karson to serve as a member of the Board
View on SEC.gov
Source: SEC EDGAR
accession 0001824293-22-000007
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.